Bio-Rad Laboratories (BIO) FCF Margin Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.00 |
| Dec 31, 2025 | -1,390.00 |
| Sep 30, 2025 | -421.00 |
| Jun 30, 2025 | -292.00 |
| Mar 31, 2025 | 910.00 |
| Dec 31, 2024 | -995.00 |
| Sep 30, 2024 | 674.00 |
| Jun 30, 2024 | -1,460.00 |
| Mar 31, 2024 | 137.00 |
| Dec 31, 2023 | 971.00 |
| Sep 30, 2023 | -294.00 |
| Jun 30, 2023 | -893.00 |
| Mar 31, 2023 | 683.00 |
| Dec 31, 2022 | -83.00 |
| Sep 30, 2022 | -396.00 |
| Jun 30, 2022 | -888.00 |
| Mar 31, 2022 | 2,843.00 |
| Dec 31, 2021 | 2,382.00 |
| Sep 30, 2021 | 1,606.00 |
| Jun 30, 2021 | 153.00 |
| Mar 31, 2021 | 1,657.00 |
| Dec 31, 2020 | 2,969.00 |
| Sep 30, 2020 | 1,769.00 |
| Jun 30, 2020 | 133.00 |
| Mar 31, 2020 | 671.00 |
| Dec 31, 2019 | 1,557.00 |
| Sep 30, 2019 | -452.00 |
| Jun 30, 2019 | 1,256.00 |
| Mar 31, 2019 | -496.00 |
| Dec 31, 2018 | -1,112.00 |
| Sep 30, 2018 | 460.00 |
| Jun 30, 2018 | 1,915.00 |
| Mar 31, 2018 | 440.00 |
| Sep 30, 2017 | -542.00 |
| Jun 30, 2017 | 770.00 |
| Mar 31, 2017 | -2,607.00 |
| Dec 31, 2016 | -1,649.00 |
| Sep 30, 2016 | 502.00 |
| Jun 30, 2016 | 39.00 |
| Mar 31, 2016 | -403.00 |
| Dec 31, 2015 | -1,138.00 |
| Sep 30, 2015 | -967.00 |
| Jun 30, 2015 | 1,585.00 |
| Mar 31, 2015 | -802.00 |
| Dec 31, 2014 | 681.00 |
| Sep 30, 2014 | -774.00 |